Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910

NCT01961414 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Exudative Age-related Macular Degeneration

Interventions

DRUG: Aflibercept

Sponsor

Palmetto Retina Center, LLC